Transmit-Power Efficient Linear Precoding Utilizing Known Interference for the Multiantenna Downlink

It has been shown that the knowledge of both channel and data information at the base station prior to downlink transmission can help increase the received signal-to-noise ratio (SNR) of each user without the need to increase the transmitted power. Achievability is based on the idea of phase alignment (PA) precoding, where instead of nulling out the destructive interference, it judiciously rotates the phases of the transmitted symbols. In this way, they add up coherently at the intended user and yield higher received SNRs. In addition, it is well known that regularized channel inversion (RCI) precoding improves the performance of channel inversion (CI) in multiantenna downlink communications. In line with this and similar to the RCI precoding, in this paper, we propose the idea of regularized PA (RPA), which is shown to improve the performance of original PA precoding. To do this, we first rectify the original PA precoding, deriving a closed-form expression to evaluate the amount of transmit-power reduction achieved for the same average output SNR compared with CI precoding. We then use this new analysis to select the appropriate regularization factor for our proposed RPA scheme. It is shown by means of theoretical analysis and simulations that the proposed RPA precoding outperforms CI, RCI, and PA precoders from both symbol error rate (SER) and throughput perspectives and provides a more power-efficient alternative. This is particularly pronounced as the number of transmit antennas becomes larger, where up to a 50-times reduction in the transmit power is achieved by RPA (PA) compared with RCI (CI) precoding for a given performance

Methods to break seed dormancy of Astragalus cyclophyllon

The aim of this study was to enhance the germination rate of Astragalus cyclophyllon seeds which have a very low germination rate under normal conditions. The seeds were soaked for 72 h in 100, 200, 300,400 and 500 ppm gibberellic acid (GA3) solution, H2SO4 concentrations (50 and 98%) at two treatment times (5 and 10 min) and 60, 80 and 100ºC hot water at two treatment times (5 and 10 min) beforeplacing in Petri dishes. The fresh seeds (non-stratified) of A. cyclophyllon had 55% germination. Analysis of variance indicated that both GA3 and H2SO4 concentrations had significant effects on seed germination and final germination percentage. The highest germination percentage (81%) was obtained when the seeds were treated with 500 ppm GA3. The results showed that hot water treatments are not useful methods for breaking the seeds dormancy

Chemical composition and evaluation of antimicrobial properties of Rosmarinus officinalis L. essential oil

Preservatives used in the food industry are undergoing increasing scrutiny and reappraisal. There is therefore a renewed interest in the antimicrobial properties of herbs and spices. Rosemary (Rosmarinus officinalis L.) belonging to the Lamiaceae family, is a pleasant-smelling perennial herb. The antimicrobial activities of the R. officinalis oil against Leuconostoc mesenteroides (PTCC1591), Lactobacillus delbruekii (PTCC1333), Saccharomyces cerevisia (PTCC5269) and Candida krusei (PTCC 5295) were determined. The results indicate that among the tested microbes, the essential oil had a stronger inhibitory effect on the bacteria as compared to yeasts. Minimum inhibitory concentration (MIC) values for bacteria L. mesenteroides, L. delbruekii, S. cerevisia and C. krusei ranged between 0.5 and 1.5 mg/ml. The oil was analyzed by GC and GC/MS. The major components of R. officinalis oil were 1,8-cineole (23.14%), camphor (12.35%), α-pinene (9.87%), β-pinene (6.10%), borneol (5.61%), camphene (5.58%) and α-terpineol (4.30%), respectively. These results indicate the latent potency of essential oil of R. officinalis as a natural preservative in food products against L. mesenteroides, L. delbruekii, S. cerevisia and C.krusei.Key words: Rosmarinus officinalis L., essential oil, chemical composition, antimicrobial properties

Ferulone A and ferulone B: two new coumarin esters from Ferula orientalis L. roots, Natural Products Research

Ferula orientalis (Apiaceae) is a well known perennial herb growing wild in Iran used in traditional medicine. To perform phytochemical studies, dried ground roots of F. orientalis were sequentially Soxhlet-extracted using n-hexane, dichloromethane and methanol. A combination of vacuum liquid chromatography and preparative thin layer chromatographic analyses were performed to isolate coumarin esters. The structures of the isolated compounds were elucidated by spectroscopic means, and in vitro free-radical-scavenging property was determined by the DPPH assay.Two new coumarin esters, 7-O-(4,8,12,16-tetrahydroxy-4,8,12,16-tetramethyl-heptadecanoyl)-coumarinand 7-O-(4-hydroxy-4,8,12-trimethyl-trideca- 7,11-dienoyl)-coumarin, named ferulone A and ferulone B, respectively, were isolated from the n-hexane extract of the roots of F. orientalis. Both compounds showed a low level of free-radical-scavenging property with the RC50 values of 0.252 and 0.556mg/mL for compounds 1 and 2, respectively, as opposed to that of the positive control (quercetin) 0.004 mg/mL. This is the first report on the purification of coumarin esters from the genus Ferula

Chemical Composition, Some Allelopathic Aspects, Free-Radical-Scavenging Property and Antifungal Activity of the Volatile Oil of the Flowering Tops of Leucanthemum vulgare Lam.

Hydrodistillation of the ground flowering tops of Leucanthemum vulgare (Asteraceae), collected from Heyran (Ardabil Province, Iran), afforded a greenish yellow oil (yield 0.15%, v/w), which was analyzed by the GC-MS and the GC-FID. The volatile oil comprised 47 compounds representing 90.3% of the oil. Caryophyllene oxide (21.2%), aromadendrene oxide (13.7%), cis-β-farnesene (6.5%), 1-octen-3-yl-acetate (5.6%) and trans-caryophyllene (4.9%) were the major compounds. The volatile oil composition of L. vulgare collected from Iran (present study) was significantly different from that collected from elsewhere, indicating two possible chemotypes. The volatile oil showed free-radical-scavenging, antifungal and allelopathic effects

Pediatric perioperative outcomes: protocol for a systematic literature review and identification of a core outcome set for infants, children, and young people requiring anesthesia and surgery

Clinical outcomes are measurable changes in health, function, or quality of life that are important for evaluating the quality of care and comparing the efficacy of interventions. However, clinical outcomes and related measurement tools need to be well‐defined, relevant and valid. In adults, Core Outcome Measures in Effectiveness Trials (COMET) methodology has been used to develop core outcome sets for perioperative care. Systematic literature reviews identified Standardized Endpoints (StEP) and valid measurement tools, and consensus across a broader range of relevant stakeholders was achieved via a Delphi process to establish Core Outcome Measures in Perioperative and Anaesthetic Care (COMPAC). Core outcome sets for pediatric perioperative care cannot be directly extrapolated from adult data. The type and weighting of endpoints within particular domains can be influenced by age‐dependent differences in the indications for and/or nature of surgery and medical co‐morbidities, and the validity and utility of many measurement tools vary significantly with developmental stage and age. Involvement of parents/carers is essential as they frequently act as surrogate responders for preverbal and developmentally delayed children, parental response may influence child outcome, and parental and/or child ranking of outcomes may differ from those of health professionals. Here we describe formation of the international Pediatric Perioperative Outcomes Group, which aims to identify and create validated, broadly applicable, patient‐centered outcome measures for infants, children and young people. Methodologies parallel that of the StEP and COMPAC projects, and systematic literature searches have been performed within agreed age‐dependent subpopulations to identify reported outcomes and measurement tools. This represents the first steps for developing core outcome sets for pediatric perioperative care

A systematic review of outcomes reported inpediatric perioperative research: A report from the Pediatric Perioperative Outcomes Group

The Pediatric Perioperative Outcomes Group (PPOG) is an international collaborative of clinical investigators and clinicians within the subspecialty of pediatric anesthesiology and perioperative care which aims to use COMET (Core Outcomes Measures in Effectiveness Trials) methodology to develop core outcome sets for infants, children, and young people that are tailored to the priorities of the pediatric surgical population. Focusing on four age‐dependent patient subpopulations determined a priori for core outcome set development: (a) neonates and former preterm infants (up to 60 weeks postmenstrual age); (b) infants (>60 weeks postmenstrual age—1‐13‐<18 years), we conducted a systematic review of outcomes reported in perioperative studies that include participants within age‐dependent pediatric subpopulations. Our review of pediatric perioperative controlled trials published from 2008 to 2018 identified 724 articles reporting 3192 outcome measures. The proportion of published trials and the most frequently reported outcomes varied across predetermined age‐groups. Outcomes related to patient comfort, particularly pain and analgesic requirement, were the most frequent domain for infants, children, and adolescents. Clinical indicators, particularly cardiorespiratory or medication‐related adverse events, were the most common outcomes for neonates and infants <60 weeks and were the second most frequent domain at all other ages. Neonates and infants <60 weeks of age were significantly under‐represented in perioperative trials. Patient‐centered outcomes, healthcare utilization, and bleeding/transfusion‐related outcomes were less often reported. In most studies, outcomes were measured in the immediate perioperative period, with the duration often restricted to the postanesthesia care unit or the first 24 postoperative hours. The outcomes identified with this systematic review will be combined with patient‐centered outcomes identified through a subsequent stakeholder engagement study to arrive at a core outcome set for each age‐specific group

Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors

The thyroid hormone and retinol transporter protein known as transthyretin (TTR) is in the origin of one of the 20 or so known amyloid diseases. TTR self assembles as a homotetramer leaving a central hydrophobic channel with two symmetrical binding sites. The aggregation pathway of TTR into amiloid fibrils is not yet well characterized but in vitro binding of thyroid hormones and other small organic molecules to TTR binding channel results in tetramer stabilization which prevents amyloid formation in an extent which is proportional to the binding constant. Up to now, TTR aggregation inhibitors have been designed looking at various structural features of this binding channel others than its ability to host iodine atoms. In the present work, greatly improved inhibitors have been designed and tested by taking into account that thyroid hormones are unique in human biochemistry owing to the presence of multiple iodine atoms in their molecules which are probed to interact with specific halogen binding domains sitting at the TTR binding channel. The new TTR fibrillogenesis inhibitors are based on the diflunisal core structure because diflunisal is a registered salicylate drug with NSAID activity now undergoing clinical trials for TTR amyloid diseases. Biochemical and biophysical evidence confirms that iodine atoms can be an important design feature in the search for candidate drugs for TTR related amyloidosis

Virulence factors and antibiotic susceptibility in enterococci isolated from oral mucosal and deep infections

This study evaluates the presence of virulence factors and antibiotic susceptibility among enterococcal isolates from oral mucosal and deep infections. Forty-three enterococcal strains from oral mucosal lesions and 18 from deep infections were isolated from 830 samples that were sent during 2 years to Oral Microbiology, University of Gothenburg, for analysis. The 61 strains were identified by 16S rDNA, and characterized by the presence of the virulence genes efa A (endocarditis gene), gel E (gelatinase gene), ace (collagen binding antigen gene), asa (aggregation substance gene), cyl A (cytolysin activator gene) and esp (surface adhesin gene), tested for the production of bacteriocins and presence of plasmids. MIC determination was performed using the E-test method against the most commonly used antibiotics in dentistry, for example, penicillin V, amoxicillin and clindamycin. Vancomycin was included in order to detect vancomycin-resistant enterococci (VRE) strains. Sixty strains were identified as Enterococcus faecalis and one as Enterococcus faecium. All the virulence genes were detected in more than 93.3% (efa A and esp) of the E. faecalis strains, while the presence of phenotypic characteristics was much lower (gelatinase 10% and hemolysin 16.7%). Forty-six strains produced bacteriocins and one to six plasmids were detected in half of the isolates. Enterococcal strains from oral infections had a high virulence capacity, showed bacteriocin production and had numerous plasmids. They were generally susceptible to ampicillins but were resistant to clindamycin, commonly used in dentistry, and no VRE-strain was found

Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand

BACKGROUND: No data currently exist about use of antibiotics to prevent surgical site infections (SSI) among patients undergoing appendectomy in Thailand. We therefore examined risk factors, use, and efficacy of prophylactic antibiotics for surgical site infection SSI among patients with uncomplicated open appendectomy. METHODS: From July 1, 2003 to June 30, 2004 we conducted a prospective cohort study in eight hospitals in Thailand. We used the National Nosocomial Infection Surveillance (NNIS) system criteria to identify SSI associated with appendectomy. We used logistic regression analysis to obtain relative risk estimates for predictors of SSI. RESULTS: Among 2139 appendectomy patients, we identified 26 SSIs, yielding a SSI rate of 1.2 infections/100 operations. Ninety-two percent of all patients (95% CI, 91.0–93.3) received antibiotic prophylaxis. Metronidazole and gentamicin were the two most common antibiotic agents, with a combined single dose administered in 39% of cases. In 54% of cases, antibiotic prophylaxis was administered for one day. We found that a prolonged duration of operation was significantly associated with an increased SSI risk. Antibiotic prophylaxis was significantly associated with a decreased risk of SSI regardless of whether the antibiotic was administered preoperatively or intraoperatively. Compared with no antibiotic prophylaxis, SSI relative risks for combined single-dose of metronidazole and gentamicin, one-day prophylaxis, and multiple-day antibiotic prophylaxis were 0.28 (0.09–0.90), 0.30 (0.11–0.88) and 0.32 (0.10–0.98), respectively. CONCLUSION: Single-dose combination of metronidazole and gentamicin seems sufficient to reduce SSIs in uncomplicated appendicitis patients despite whether the antibiotic was administered preoperatively or intraoperatively